
|Articles|May 12, 2004
BPH treatment reduces symptoms, urinary retention
Finasteride (Proscar) is indicated for the treatment of symptomatic BPHin men with an enlarged prostate to improve symptoms and to reduce the riskof acute urinary retention and BPH-related surgery.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










